ExpressPoints
Guideline Updates and Real-World Experiences in CLL: State-of-the-Art Evidence and Next Questions

Download this short slideset of key takeaways from a live NCCN/CCO Webinar focused on current treatment in CLL/SLL.
Jeremy S. Abramson, MD, MMSc
Anthony Mato, MD, MSCE
William G. Wierda, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 3.14 MB
Released: June 15, 2021

Acknowledgements

Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC.
NCCN Logo

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
AstraZeneca
BeiGene, Ltd.
Lilly
Pharmacyclics LLC and Janssen

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Related Content

Downloadable slideset of FcRn pathway inhibition in patients with ITP, from Clinical Care Options (CCO)

David J. Kuter, MD, DPhil Released: July 23, 2021

Downloadable slideset of BTK inhibitors in patients with ITP, from Clinical Care Options (CCO)

David J. Kuter, MD, DPhil Released: July 23, 2021

Downloadable slideset of an expert’s overview of emerging therapies for patients with ITP, from Clinical Care Options (CCO)

David J. Kuter, MD, DPhil Released: July 23, 2021

Downloadable slideset of complement inhibition in patients with ITP, from Clinical Care Options (CCO)

person default Catherine M. Broome, MD Released: July 23, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue